GIUSSANI, PAOLA CARLA
 Distribuzione geografica
Continente #
EU - Europa 8.216
NA - Nord America 7.659
AS - Asia 6.874
SA - Sud America 701
AF - Africa 123
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 13
Totale 23.635
Nazione #
US - Stati Uniti d'America 7.429
GB - Regno Unito 2.284
CN - Cina 2.280
SG - Singapore 2.094
IT - Italia 1.631
DE - Germania 1.349
SE - Svezia 713
HK - Hong Kong 604
RU - Federazione Russa 569
BR - Brasile 525
VN - Vietnam 440
IN - India 353
FR - Francia 325
NL - Olanda 254
UA - Ucraina 240
TR - Turchia 224
BD - Bangladesh 210
KR - Corea 205
FI - Finlandia 191
IE - Irlanda 180
JP - Giappone 156
CA - Canada 132
EU - Europa 99
ID - Indonesia 87
DK - Danimarca 86
CO - Colombia 78
PL - Polonia 61
ES - Italia 60
BE - Belgio 57
GR - Grecia 46
MX - Messico 43
CI - Costa d'Avorio 40
AU - Australia 37
CH - Svizzera 37
AR - Argentina 36
IQ - Iraq 33
RO - Romania 28
SA - Arabia Saudita 23
CZ - Repubblica Ceca 22
TW - Taiwan 22
ZA - Sudafrica 22
AT - Austria 19
PH - Filippine 15
PK - Pakistan 15
VE - Venezuela 15
UZ - Uzbekistan 14
MA - Marocco 13
EC - Ecuador 12
AZ - Azerbaigian 11
CL - Cile 11
IR - Iran 11
CR - Costa Rica 10
IL - Israele 10
NZ - Nuova Zelanda 10
SK - Slovacchia (Repubblica Slovacca) 10
EG - Egitto 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
HU - Ungheria 8
PY - Paraguay 8
SC - Seychelles 8
UY - Uruguay 8
HR - Croazia 7
JM - Giamaica 7
JO - Giordania 7
LB - Libano 7
LT - Lituania 7
NI - Nicaragua 7
NO - Norvegia 7
AL - Albania 6
NP - Nepal 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
GE - Georgia 5
GT - Guatemala 5
KE - Kenya 5
MY - Malesia 5
BO - Bolivia 4
DZ - Algeria 4
KZ - Kazakistan 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
LU - Lussemburgo 3
MU - Mauritius 3
NG - Nigeria 3
PE - Perù 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
BZ - Belize 2
CY - Cipro 2
KG - Kirghizistan 2
KW - Kuwait 2
PR - Porto Rico 2
SI - Slovenia 2
Totale 23.700
Città #
Southend 2.014
Singapore 1.275
Ashburn 803
Milan 738
Chandler 624
Hong Kong 543
San Jose 513
Beijing 495
Seattle 328
Dallas 307
Wilmington 281
Hanover 273
Princeton 242
Council Bluffs 233
Houston 204
Los Angeles 201
Frankfurt am Main 200
Ann Arbor 195
Fairfield 189
Dublin 178
Jacksonville 175
Santa Clara 144
Dearborn 143
Ho Chi Minh City 134
Nanjing 132
Bengaluru 114
New York 113
Mountain View 111
Redmond 109
Lauterbourg 106
Hanoi 104
Woodbridge 102
Boardman 93
Redwood City 92
Moscow 91
Hefei 88
Buffalo 86
Somerville 84
Guangzhou 83
Cambridge 82
Shanghai 81
Des Moines 78
Helsinki 75
Bogotá 71
Sakarya 70
Serra 70
São Paulo 68
Jinan 67
Tokyo 62
Andover 60
Jakarta 57
Phoenix 54
Shenyang 51
The Dalles 51
Medford 50
Toronto 50
Berlin 49
Brussels 49
Tianjin 46
Columbus 45
Hebei 44
Nanchang 43
Warsaw 43
Athens 41
Abidjan 40
Cangzhou 39
Kiez 35
Seoul 34
Changsha 32
Kent 32
Istanbul 31
Nürnberg 30
Shenzhen 30
Jiaxing 26
Nuremberg 26
Orem 26
Sunnyvale 26
Turin 26
Fuzhou 25
Hangzhou 25
Munich 25
Zhengzhou 25
Naples 24
Chicago 23
Montreal 23
Bitonto 22
Bühl 22
Dong Ket 22
Grafing 22
Kunming 22
Rome 22
Wuhan 21
London 20
San Diego 20
Fremont 19
Baghdad 18
Rio de Janeiro 18
Auburn Hills 17
Brooklyn 17
Odernheim 17
Totale 14.299
Nome #
Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases 548
Proteomic analysis of human glioblastoma cell lines differently resistant to a nitric oxide releasing agent 517
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure 506
Extracellular Sphingosine-1-Phosphate Downstream of EGFR Increases Human Glioblastoma Cell Survival 418
Role of sphingolipids in the biogenesis and biological activity of extracellular vesicles 414
Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures 354
Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases 347
The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders 318
Sphingolipids : key regulators of apoptosis and pivotal players in cancer drug resistance 311
Nitric oxide modulates ceramide traffic in human glioma cells : a fluorescence microscopy study 302
Crosstalk between sphingosine-1-phosphate and EGFR signalling pathways enhances human glioblastoma cell invasiveness 289
Luteolin induces an alteration of the Ceramide/Sphingosine-1-phosphate ratio leading to apoptosis in human colon cancer cells 288
Isolation and analysis of lipid rafts from neural cells and tissues 288
Evidence for the involvement of lipid rafts and plasma membrane sphingolipid hydrolases in pseudomonas aeruginosa infection of cystic fibrosis bronchial epithelial cells 284
Sphingolipids role in the regulation of inflammatory response: From leukocyte biology to bacterial infection 278
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 278
Extracellular sphingosine-1-phosphate : a novel actor in human glioblastoma stem cell survival 273
Luteolin induces apoptosis in human colon cancer cells by inhibiting ceramide traffic and metabolism 250
Ceramide acts as a mediator of the antiproliferative and pro-death effects of the natural flavonoid luteolin in human colon cancer cells 241
Glucolipotoxicity impairs ceramide flow from the endoplasmic reticulum to the Golgi apparatus in INS-1 b-Cells 238
Microvesicles shed from microglia represent a new pathway of glia-to neuron communication 237
Sphingosine-1-P and its plasma membrane receptors in human glioma cells 234
Proteomic Analysis of Human Glioblastoma Cell Lines with Different Response to Nitric Oxide 231
Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival 231
Sphingosine 1 phosphate enhances the survival oh human glioblastoma stem cells 230
A sphingosine-1-phosphate autocrine loop protects glioblastoma stem cells against death 227
Role of "sphingolipid rheostat" in mediating the apoptotic effect of luteolin in colon cancer cells 227
The role of sphingolipids in cancer immunotherapy 227
Alteration of glycosphingolipid levels and overexpression of GlcCer synthase are associated to acquired resistance to unrelated drugs in human glioma cells 222
Microvesicles shed from microglia represent a new pathway of glia-to-neuron communication 221
Roles of sphingolipid metabolism in pancreatic β cell dysfunction induced by lipotoxicity 219
Regulation of ceramide metabolism in glioma cells : evidence on the role of phosphatidylinosotol-4-kinases 218
The ceramide transfer protein CERT as a regulator of life and death in glioma cells 216
Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles 215
Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors 213
Crosstalk between S1P and EGFR signalling pathways in human glioma cell invasiveness 212
Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism 211
Cell communication in the nervous system : the mediator role of sphingosine 1-phosphate 210
Ceramide in nitric oxide inhibition of glioma cell growth. Evidence for the involvement of ceramide traffic 208
Ceramide flow from the endoplasmic reticulum to the Golgi apparatus is impaired in glucolipotoxic conditions in INS-1 beta cells 207
Alterations of ceramide-metabolizing enzymes in human glioblastoma cells resistant to unrelated drugs 206
Ceramide induces autophagic death and HMGB1 release in human glioma cells 205
Metabolic and functional role of the ceramide binding protein CERT in glioma cells 204
Evidence on the role of phosphoinositides on ceramide metabolism in glioma cells 204
Soluble factors produced by T98G glioma cells induce sphingosine kinase 2 overexpression to stimulate extracellular S1P release from brain bEnd5 endothelial cells 202
Sphingosine-1-phosphate promotes survival against etoposide by enhancing ceramide transport from ER to Golgi apparatus in T98G glioma cells 201
Extracellular sphingosine-1-phosphate provides a survival advantage over autophagic death in human glioblastoma cells 201
Galactocerebrosidase deficiency induces an increase in lactosylceramide content: A new hallmark of Krabbe disease? 201
Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation 200
Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells 200
Phosphatidylinositol 3-Kinase/AKT pathway regulates the endoplasmic reticulum to Golgi traffic of ceramide in glioma cells : a link between lipid signaling pathways involved in the control of cell survival 199
Sphingosine-1-phosphate as survival factor in etoposide-induced cytotoxicity in glioma cells: role of PI3K/Akt-dependent stimulation of endoplasmic reticulum (ER) to Golgi apparatus ceramide traffic 199
Glucosylceramide Synthase protects Glioblastoma cells against autophagic and apoptotic death induced by temozolomide and paclitaxel 197
Extracellular sphingosine-1-phosphate contributes to survival properties of glioblastoma stem cells 197
Sphingosine-1-phosphate/ceramide ratio is related to acquired temozolomide resistance in human malignant glioma cells 195
Role of ceramide transfer protein CERT as a regulator of glioma cell proliferation 195
Pathogenic role of microglia-derived microvesicles in neuroinflammation and neurodegeneration 195
Ceramide glucosylation is increased in a human glioma cell line resistant to temozolomide 193
Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells 192
Basic fibroblast growth factor-induced proliferation of primary astrocytes 192
Caseinphosphopeptides as bio modulators of intestinal cell functions related to normal/tumor phenotypes 192
The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy 190
Ceramide and sphingosine-1-phosphate exert opposite roles on autophagic death of malignant glioma cells 188
Autocrine sphingosine-1-phosphate fuels growth and stemness in glioblastoma stem cells 188
HMGB1 as an autocrine stimulus in human T98G glioblastoma cells : role in cell growth and migration 187
Extracellular high mobility group box 1 protein stimulates proliferation and mobility in human glioma cells 186
Ganglioside enrichment and enhanced sphingosine-1-phosphate secretion contribute to drug resistance in human glioblastoma cells 184
Involvement of PI3K/Akt in the ER to golgi traffic of ceramide in glioma cells : a link between lipid signalling pathways involved in the control of cell survival 179
Sphingosine-1-phosphate secretion and signaling provide survival advantages to human glioblastoma cells 179
Ceramide in beta cells apoptosis induced by gluco-lipotoxicity:possible role of cer flow for the biosynthesis of complex sphingolipids 179
Ceramide induces autophagic death and HMGB1 release in human glioma cells 178
Ceramide traffic in C6 glioma cells: evidence for CERT-dependent and independent transport from ER to the Golgi apparatus 176
HMGB1 as an extracellular signal in T98G glioma cells 176
Microvesicles shed from microglial cells upon ATP activation: a new pathway of glia-to-neuron communication 176
Sphingosine-1-phosphate in human glioma cells 174
A mediator role of ceramide in neuronal cell differentiation 174
Effect of sphingosine-1-phosphate on calcium signaling in cerebellar astrocytes and neurons 173
Overexpression of glucosyl-ceramide synthase is associated with acquired resistance to unrelated drugs in human glioma cells 172
Extracellular sphingosine-1-phosphate in glioma cell growth 172
Casein phosphopeptides modulate calcium uptake and apoptosis in Caco2 cells through their interaction with the TRPV6 calcium channel 172
Nitric oxide modulates ceramide metabolism in human glioma cells 171
Sphingosine-1-phosphate metabolism and role as a paracrine/autocrine signal in human glioma cells 170
EXTRACELLULAR SPHINGOSINE-1-PHOSPHATE ACTS AS A SURVIVAL FACTOR FOR HUMAN GLIOBLASTOMA STEM CELLS 169
Ceramide in gluco-lipotoxicity: possible impairment of ceramide flowing in complex sphingolipid biosynthesis in beta pancreatic cells 166
Extracellular sphingosine-1-phosphate acts as a survival factor for human glioblastoma stem cells 166
Impaired Autophagy in Krabbe Disease: The Role of BCL2 and Beclin-1 Phosphorylation 165
Crosstalk between PI3K-Akt-PTEN and ceramide signaling in the control of glioma fate 164
Effect of nitric oxide on ceramide traffic in human glioma cells 164
Sphingosine-1-phosphate (S1P) impacts presynaptic functions by regulating synapsin i localization in the presynaptic compartment 164
Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy 162
Role of ceramide and sphingosine-1-phosphate in the regulation of glioma cell death and survival 161
Role of sphingosine-1-phosphate phosphatase 1 in epidermal growth factor-induced chemotaxis 160
Sphingolipid transport 160
Ceramide and sphingosine-1-phosphate in glial cells 160
Cell communication in the nervous system : the mediator role of sphingosine-1-phosphate 160
Sphingosine-1-phosphate in the signaling between endothelial and glioma cells 158
Changes in glycosphingolipid content and overexpression of glucosyl-ceramide synthase are associated with acquired resistance to unrelated drugs in T98G human glioma cells 157
Sphingosine-1-phosphate in astroglial cells 155
Behaviour of nitric oxide synthase in rat cerebellar granule cells differentiating in culture 155
Role of CERT in the targeting of ceramide to the Golgi apparatus in glioma cells 154
Totale 21.972
Categoria #
all - tutte 62.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021387 0 0 0 0 0 0 0 0 0 0 307 80
2021/20221.907 208 69 69 111 231 113 159 110 190 216 97 334
2022/20231.964 275 226 172 233 228 354 35 122 199 19 66 35
2023/20241.300 54 86 64 142 360 58 55 122 30 60 101 168
2024/20253.514 152 326 57 310 334 126 215 343 209 276 311 855
2025/20266.603 684 432 684 506 662 455 989 328 750 524 589 0
Totale 24.749